Sakar Healthcare Ltd

Sakar Healthcare Ltd Share Price Today: Live Updates & Key Insights

Get insights on Sakar Healthcare Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.

Sakar Healthcare Ltd Share Price Chart

stocks
To Invest in Sakar Healthcare Ltd
stocks

null at 10 Jul 2026 06:13 PM null

N/A 0.00(0.00%)

Lowest Today 0.00

Highest Today 0.00

Today's Open 0.00

Prev. Close 0.00

52 Week High 0.00

52 Week Low 0.00

Sakar Healthcare Ltd Fundamentals

Traded Volume: N/A

Market Cap(Cr): N/A

Avg Traded Price N/A

1 Year return %

Upper Circuit N/A

Lower Circuit N/A

P/E TTM 0.00

P/B Ratio 0.00

Traded Value(Cr) N/A

EPS TTM NaN

Book value/Share NaN

Dividend Yield 1Y 0.00%

Sakar Healthcare Ltd Share Price Performance

Shows the percentage change in stock price over different time periods

This section highlights Sakar Healthcare Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Sakar Healthcare Ltd share price history, short-term movements, long-term trends, and overall investor sentiment

1W -1.16%

1M +1.34%

3M +44.06%

1Y 0.00%

YTD +96.69%

Sakar Healthcare Ltd Traded Volume Movement

Shows the trading volume over different time periods

This section highlights Sakar Healthcare Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment

Yesterday 87787.00

Day Before Yesterday 1.09L

1W Avg 1.49L

1M Avg 1.37L

3M Avg 1.94L

Sakar Healthcare Ltd Technical Details

Sakar Healthcare Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.

Support 1 N/A

Support 2 N/A

Support 3 N/A

Pivot Point : N/A

Resistance 1 N/A

Resistance 2 N/A

Resistance 3 N/A

Sakar Healthcare Ltd Corporate Actions

Sakar Healthcare Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Sakar Healthcare Ltd’s capital allocation strategies.

All

Dividends

No Dividend has been declared by null

Bonus

No Bonus has been declared by null

Splits

No Split has been declared by null

Others

Rights No Rights has been declared by null

Sakar Healthcare Ltd Peer Comparison

Shows key financial metrics for the company and its peers

This section compares Sakar Healthcare Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Sakar Healthcare Ltd's relative performance and valuation against major competitors.

Stock Name Alembic Ltd ₹89.97 (+1.36%) M. Cap (Cr) 23.10 1 Yr Return (%) -23.19% P/E (TTM) 7.28 PB Ratio 0.94

Stock Name Ind-Swift Laboratories Ltd ₹246.44 (+4.61%) M. Cap (Cr) 21.43 1 Yr Return (%) +111.12% P/E (TTM) 51.75 PB Ratio 1.55

Stock Name NGL Fine Chem Ltd ₹3193.60 (-0.55%) M. Cap (Cr) 19.74 1 Yr Return (%) +149.99% P/E (TTM) 41.07 PB Ratio 5.99

Stock Name Sakar Healthcare Ltd ₹824.50 (+3.02%) M. Cap (Cr) 18.35 1 Yr Return (%) +134.57% P/E (TTM) 60.18 PB Ratio 5.65

Stock Name Hester Biosciences Ltd ₹2118.00 (+0.75%) M. Cap (Cr) 18.02 1 Yr Return (%) +16.83% P/E (TTM) 32.43 PB Ratio 5.01

Stock Name Windlas Biotech Ltd ₹829.95 (+0.49%) M. Cap (Cr) 17.13 1 Yr Return (%) -10.55% P/E (TTM) 26.21 PB Ratio 3.00

Stock Name Amrutanjan Health Care Ltd ₹538.20 (+0.49%) M. Cap (Cr) 15.56 1 Yr Return (%) -25.01% P/E (TTM) 26.87 PB Ratio 4.20

Sakar Healthcare Ltd Cash Flow

Cash flow data provides a view of how money is generated and spent by Sakar Healthcare Ltd, across its operating activities, investing activities, and financing activities.

Sakar Healthcare Ltd Shareholding Pattern

This shows the ownership breakdown of Sakar Healthcare Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.

Promoter N/A%

Public N/A%

Other Institutions N/A%

FII N/A%

Mutual Funds N/A%

About Sakar Healthcare Ltd

Sakar Healthcare Limited was incorporated as a Private Limited Company under the name Sakar Healthcare Private Limited on 26th March 2004. Subsequently, the Company was converted into Public Limited Company on March 27, 2015 and the name of the Company was changed to Sakar Healthcare Limited. The Company is promoted by Sanjay Shah, Rita Shah and Aarsh Shah.The Company is engaged in manufacturing of Pharmaceutical products providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Dry Powder Injections, Liquid Injectables (SVP) in Ampoules and Vials & Lyophilized Injections and Oral Solid Dossages. It manufactures and markets pharmaceutical formulations relating to analgesics, anti coagulants, anti malarial, anti spasmodic, antianemics, antibiotics, anti-emetics, anti-histamines, bronchodilators, corticosteroids, cough and cold preparations, multivitamins, etc.The Company operates as contract development and manufacturing organisation (CDMO), being the EU GMP approved CMO for leading multinational pharmaceutical companies.Their 4 manufacturing facilities located at Changodar, Ahmedabad, Gujarat. have been approved by various international regulatory authorities and certified by ISO 9001:2008 (BVQI), WHO-GMP, CGMP & National Drug Authority, and it has obtained certain drug specific registrations from the relevant authorities in countries such as Uganda, Kenya, Yemen, Ethiopia, Congo, Ghana, Zimbabwe, Namibia, Nigeria, Cote d'ivoire.In 2005, the Company started commercial production for Plant - 1 which was established for production of Liquid Orals; in 2007, it started exporting its products overseas; started commercial production for Plant - 2 which was established for production of Beta Lactum Tablet and Capsules and Dry Syrup B-lactum. / Sachet in 2008. Further, it started commercial production for Plant - 3 which was established for production of Liquid Injectibles (SVP) - Ampoules and Liquid Injectibles (SVP) - Vials.In 2012, it started commercial production for Plant - 4 which was established for production of Dry Powder Injection. In 2017, it started Lyophilised injection product commercialisation.In 2020, the Company received EU GMP certification for SVP unit manufacturing liquid and Lyophilised injections. In 2021, the Oncology Unit started operations in Bavla location. In 2022-23, the Company started commercialization with Oncology product post receiving WHO GMP certification.The Company granted a patent for IMATINIB and the EU GMP certification and began oncology unit to export oncology products in FY 2025.

Chairman & Managing Director

Sanjay S Shah.

Registered office 10/13 Nr MN Desai Petrol Pump, Sarkhej Bavla Highway, Changodar, Gujarat, 382213

FAX :91-2717-250477

Background

Incorporation Year 2004

Face Value ₹10.00

Market Lot 1

Sakar Healthcare Ltd Latest News

news-by-symbol

VIEW MORE NEWS

FAQs on Sakar Healthcare Ltd

How to buy Sakar Healthcare Ltd shares?

To buy Sakar Healthcare Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.

What is the market cap of Sakar Healthcare Ltd?

The company has a market capitalization of ₹N/A.

What is the PE & PB ratio of Sakar Healthcare Ltd?

PE is N/A and PB is N/A.

What is the Sakar Healthcare Ltd dividend for 2025–26?

For the 2025–26 financial year, Sakar Healthcare Ltd declared a final dividend of null% per share.